Decreased cell proliferation in the PP-treated infarcted heart in a mouse model of myocardial infarction. by Motoaki Murakoshi (479700)

Decreased expression of synaptopodin and RhoA. by Sandra Müller-Krebs (485766)

Fungal infection decreases cell proliferation. by Mariem Ben-Abdallah (181235)

Decrease of the viral infectivity titer by marchantins. by Yuma Iwai (220294)

“…The cells were then treated with various concentrations of phytochemicals (3.1–50 µM), some of which decreased viral infectivity titer. …”

Inhibition of coactivator expression by RNAi decreases PPARα activity in a ligand-specific manner by Eric S. Tien (22393)

ATRA decreased TGF-β1 content in LT cultures in a concentration-dependent manner. by Carmen Retana (479628)

Purified apolipoproteins decrease endothelial exocytosis. by Scott J. Cameron (838315)

p120ctn depletion decreases directional persistence of cells migrating into a scratch wound. by Sandra Kümper (245458)

Pharmacological treatments decrease actin polymerization. by Romain Ferru-Clément (701878)

CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

“…(F) Increasing concentrations to 50 nM still enhances clonogenic survival of HBEC 30KT, but actually seems to decrease survival in HCC 4017 after 3 Gy radiation. …”

Simulated effects of increased pCREB combined with decreased pCaMKIIα on bistability. by Yili Zhang (540283)

“…However, decreasing <i>k</i>_{<i>basalp_CaMKII</i>} by ~50% blocked the bistable switch (red). …”

K562 cells treated with 25, 50, and 75 μM of hemin for 48 h. by Tipparat Penglong (164413)

m 6A RNA Methylation Decreases Atherosclerotic Vulnerable Plaque Through Inducing T Cells by Chunmei Qi (739294)

“…Conclusion: After successfully establishing a vascular parkinsonism rabbit model, m 6A RNA methylation can decrease Th cells and vulnerable atherosclerotic plaques.…”

NEMO knockout murine dermal fibroblasts show a decreased nuclear translocation of p65. by Patrick Meyer (3395285)

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

“…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”

Overexpression of DHCR24 on the cell surface of HCC cell lines was decreased by treatment with U18666A and cyclosporin A. by Makoto Saito (721667)

MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

AAV-mediated Atp6v1c1 knockdown decreased TRAP positive cells and Atp6v1c1 expression in the periodontitis lesion area. by Sheng Li (107261)

PT₅₀ values of GO and GO-GA NPs against <i>Callosobruchus maculatus.</i> by Huda H. Elbehery (22492996)

DJA2 decreases maturation of CFTR. by Patrick Kim Chiaw (7224539)